Screener
Merck & Co. MRK AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Merck & Co.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:10 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0001628280-26-029802
FAQ
- What is Merck & Co.'s AOCI?
- Merck & Co. (MRK) reported AOCI of -$4.06B in Q1 2026.
- How has Merck & Co.'s AOCI changed year-over-year?
- Merck & Co.'s AOCI increased by 18.2% year-over-year, from -$4.97B to -$4.06B.
- What is the long-term trend for Merck & Co.'s AOCI?
- Over 5 years (2020 to 2025), Merck & Co.'s AOCI has grown at a -8.4% compound annual growth rate (CAGR), from -$6.63B to -$4.29B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Merck & Co.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude